GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incanthera PLC (AQSE:INC) » Definitions » Other Stockholders Equity

Incanthera (AQSE:INC) Other Stockholders Equity : £4.19 Mil (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Incanthera Other Stockholders Equity?

Incanthera's Other Stockholders Equity for the quarter that ended in Sep. 2023 was £4.19 Mil.

Incanthera's quarterly Other Stockholders Equity increased from Sep. 2022 (£4.01 Mil) to Mar. 2023 (£4.12 Mil) and increased from Mar. 2023 (£4.12 Mil) to Sep. 2023 (£4.19 Mil).

Incanthera's annual Other Stockholders Equity increased from Mar. 2021 (£3.81 Mil) to Mar. 2022 (£3.95 Mil) and increased from Mar. 2022 (£3.95 Mil) to Mar. 2023 (£4.12 Mil).


Incanthera Other Stockholders Equity Historical Data

The historical data trend for Incanthera's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Incanthera Other Stockholders Equity Chart

Incanthera Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Other Stockholders Equity
3.30 3.81 3.95 4.12

Incanthera Semi-Annual Data
Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Other Stockholders Equity Get a 7-Day Free Trial 3.83 3.95 4.01 4.12 4.19

Incanthera Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Incanthera Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Incanthera's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Incanthera Business Description

Traded in Other Exchanges
N/A
Address
76 King Street, Manchester, GBR, M2 4NH
Incanthera PLC is a specialist dermatology and oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops solutions to current clinical, commercially relevant unmet needs, utilising a new technology. The company's current products are Sol, EP0015, Equin and Duo-C. The company has one segment, namely the development of pharmaceutical products all within the United Kingdom.

Incanthera Headlines